COMMUNIQUÉS West-GlobeNewswire
-
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
05/03/2026 -
Press Release: Sanofi’s Board of Directors proposes the appointment of Christel Heydemann as an independent director
05/03/2026 -
Oculis Publishes 2025 Consolidated Financial Statements
05/03/2026 -
Phonak Infinio Ultra Sphere and Virto R Infinio win 2026 iF DESIGN AWARD
05/03/2026 -
NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES ISSUANCE OF A NEW SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM
05/03/2026 -
BioVersys to Report Its Full Year 2025 Financial Results, Provide a Business Update and Host a Conference Call
05/03/2026 -
Medline Inc. announces pricing of secondary offering of class A common stock
05/03/2026 -
Purisaki Berberine Patches Claims Evaluated: 2026 Consumer Report on Transdermal Berberine Delivery, Patch Absorption Science, and What Buyers Should Verify
05/03/2026 -
SugarHarmony Consumer Concerns Under Investigation: Critiquing The Sugar Harmony Claims
05/03/2026 -
Monthly information on share capital and company voting rights
04/03/2026 -
SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update
04/03/2026 -
Galapagos Receives Transparency Notifications from Bank of America
04/03/2026 -
DBV Technologies to Participate in Upcoming March Investor Conferences
04/03/2026 -
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
04/03/2026 -
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars
04/03/2026 -
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
04/03/2026 -
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
04/03/2026 -
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/03/2026 -
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
04/03/2026
Pages